FLJ14213 (N-Term) anticorps
Aperçu rapide pour FLJ14213 (N-Term) anticorps (ABIN629854)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- FLJ14213 antibody was raised against the N terminal of FLJ14213
-
Purification
- Purified
-
Immunogène
- FLJ14213 antibody was raised using the N terminal of FLJ14213 corresponding to a region with amino acids SAWNSVQTAVINVFKGGGLQSNELYALNENIRRLLKSELGSFITDYFQNQ
-
-
-
-
Indications d'application
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
FLJ14213 Blocking Peptide, (ABIN5613604), is also available for use as a blocking control in assays to test for specificity of this FLJ14213 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FLJ14213 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- FLJ14213
-
Sujet
- FLJ14213 may be part of the TORC2 complex which plays a critical role in AKT1 'Ser-473' phosphorylation, and may modulate the phosphorylation of PKCA and regulate actin cytoskeleton organization
-
Poids moléculaire
- 40 kDa (MW of target protein)
Antigène
-